Tissue microarrays: a current medical research tool

References

• Williamson M, Naaby-Hansen S, Masters JR. 21st century molecular biology in urology. BJU Int 2001;88:451–57
   PubMed Web of Science ®Google Scholar
• Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822–26
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406(6797):747–52
   PubMed Web of Science ®Google Scholar
• Zou TT, Selaru FM, Xu Y, et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002;21(31):4855–62
   PubMed Web of Science ®Google Scholar
• Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001;98(17):9754–9
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M. Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer. Clin Chem 2003;49:23–31
   PubMed Web of Science ®Google Scholar
• Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 1986;55:24–8
   Web of Science ®Google Scholar
• Battifora H, Mehta P. The checkerboard tissue block. An improved multitissue control block. Lab Invest 1990;63(5):722–4
   Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844–47
   PubMed Web of Science ®Google Scholar
• http://www.beecherinstruments.com [Accessed 1 February 2004]
   Google Scholar
• http://www.pathology.pitt.edu/apiii02/apiii2002_SHewitt/S-Hewitt-APIII-02x.html [Accessed 1 February 2004]
   Google Scholar
• Fejzo MS, Slamon DJ. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 2001;159(5):1645–50
   PubMed Web of Science ®Google Scholar
• Brandt B, Roetger A, Bidart JM, et al. Early placental insulin-like growth factor (pro-Epil) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. Cancer Res 2002;62:1020–4.
   PubMed Web of Science ®Google Scholar
• Simon R, Struckmann K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary tract bladder cancer. Oncogene 2002;21,2476–83
   PubMed Web of Science ®Google Scholar
• Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi OP. Clinical and functional target validation using tissue and cell microarrays. Curr Opin Chem Biol 2002;6:97–101
   Google Scholar
• Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 2001; 70:255–64
   Google Scholar
• Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003;16(1):79–84
   PubMed Web of Science ®Google Scholar
• Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312–19
   PubMed Web of Science ®Google Scholar
• Mucci NR, Akdas G, Manely S, Rubin MA. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 2000;31(4):406–14
   PubMed Web of Science ®Google Scholar
• Nocito A, Bubendorf L, Maria Tinner E, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349–57
   PubMed Web of Science ®Google Scholar
• Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158(4):1245–51
   PubMed Web of Science ®Google Scholar
• Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943–9
   Google Scholar
• Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657–62
   PubMed Web of Science ®Google Scholar
• Andersen CL, Monni O, Wagner U, et al. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol 2002;161(1):73–9
   PubMed Web of Science ®Google Scholar
• Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999;5:1966–75
   PubMed Web of Science ®Google Scholar
• Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419:624–29
   PubMed Web of Science ®Google Scholar
• Simon R, Nocito A, Hubscher T, et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001;93(15):1141–6
   PubMed Web of Science ®Google Scholar
• Simon R, Struckmann K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002;21(16):2476–83
   PubMed Web of Science ®Google Scholar
• Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 1999;154:981–6
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 2003;95:661–8
   Google Scholar
• De la Taille A, Viellefond A, Berger N, et al. Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays. Hum Pathol 2003;34(5):444–9
   PubMed Web of Science ®Google Scholar
• Packeisen J, Buerger H, Krech R, et al. Multi tissue arrays – a new approach for quality control in immunohistochemistry. J Clin Pathol 2002;55:613–5
   PubMed Web of Science ®Google Scholar
• Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 2002;117:723–8
   PubMed Web of Science ®Google Scholar
• Hsu FD, Nielsen TO, Alkushi A, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002;15:1374–80
   PubMed Web of Science ®Google Scholar
• Mengel M, von Wasielewski R, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 2002;198: 292–9
   Google Scholar
• Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H. Demystified...tissue microarray technology. Mol Pathol 2003;56(4):198–204
   PubMedGoogle Scholar
• http://www.chemicon.com/company/PR/Arrayer.asp [Accessed 1 February 2004]
   Google Scholar
• http://www.bacuslabs.com/WebSlideOverview.html [Accessed 1 February 2004]
   Google Scholar
• Bova GS, Parmigiani G, Epstein JI, Wheeler T, Mucci NR, Rubin MA: Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. Hum Pathol 2001;32:417–27
   PubMed Web of Science ®Google Scholar
• Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8:1323–7
   Google Scholar
• Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557–65
   PubMed Web of Science ®Google Scholar
• http://ccr.cancer.gov/tech_initiatives/tarp/ [Accessed 1 February 2004]
   Google Scholar